Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Melanoma Stage IV”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT03190824
What this trial is testing

Evaluate Efficacy, Immunological Response of Intratumoral/Intralesional Oncolytic Virus (OBP-301) in Metastatic Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage Iv
Syneos Health 4
Testing effectiveness (Phase 2)Study completedNCT01950390
What this trial is testing

Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

Who this might be right for
Stage IIIC Cutaneous Melanoma AJCC v7Stage IV Cutaneous Melanoma AJCC v6 and v7Unresectable Melanoma
National Cancer Institute (NCI) 169
Testing effectiveness (Phase 2)Ended earlyNCT02718391
What this trial is testing

Complementary Vaccination With Dendritic Cells Pulsed With Autologous Tumor Lysate in Resected Stage III and IV Melanoma Patients.

Who this might be right for
Malignant MelanomaAdjuvant Drug TherapyVaccin Therapy
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 12
Large-scale testing (Phase 3)Active Not RecruitingNCT06500455
What this trial is testing

Testing Longer Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With Cancer That Has Spread to the Brain

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Digestive System Carcinoma+7 more
NRG Oncology 274
Post-approval studies (Phase 4)Not Yet RecruitingNCT07459543
What this trial is testing

Assess the Safety, and Tolerability of Nivolumab + Relatlimab Fixed-Dose Combination (FDC) In Unresectable or Metastatic Melanoma Participants In India

Who this might be right for
Unresectable MelanomaMetastatic Melanoma
Bristol-Myers Squibb 40
Early research (Phase 1)Study completedNCT00512889
What this trial is testing

Adoptive Transfer of MART1/Melan-A CTL for Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Dana-Farber Cancer Institute 9
Testing effectiveness (Phase 2)Ended earlyNCT00145145
What this trial is testing

Immunization With the MAGE-3.A1 Peptide Mixed With the Adjuvant CpG 7909 in Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Ludwig Institute for Cancer Research 1
Testing effectiveness (Phase 2)Ended earlyNCT03325101
What this trial is testing

Dendritic Cell Therapy With Pembrolizumab for Metastatic or Unresectable Melanoma

Who this might be right for
Stage III Cutaneous Melanoma AJCC v7Stage IIIA Cutaneous Melanoma AJCC v7Stage IIIB Cutaneous Melanoma AJCC v7+2 more
Mayo Clinic 7
Early research (Phase 1)Study completedNCT00028431
What this trial is testing

Novel Adjuvants for Peptide-Based Melanoma Vaccines

Who this might be right for
Melanoma
University of Southern California 19
Large-scale testing (Phase 3)Study completedNCT02545075
What this trial is testing

A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine

Who this might be right for
Melanoma
Bristol-Myers Squibb 182
Testing effectiveness (Phase 2)Looking for participantsNCT05251389
What this trial is testing

FMT to Convert Response to Immunotherapy

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
The Netherlands Cancer Institute 24
Post-approval studies (Phase 4)Looking for participantsNCT03340506
What this trial is testing

Dabrafenib and/or Trametinib Rollover Study

Who this might be right for
MelanomaNon Small Cell Lung CancerSolid Tumor+2 more
Novartis Pharmaceuticals 100
Large-scale testing (Phase 3)Study completedNCT00016263
What this trial is testing

Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma

Who this might be right for
Melanoma (Skin)
Genta Incorporated
Early research (Phase 1)Ended earlyNCT04904185
What this trial is testing

ImmPACT Expanded Multiple Antigen Specific Endogenously Derived T Cells (MASE-T) to Patients With Metastatic Melanoma

Who this might be right for
Malignant Melanoma
Inge Marie Svane 8
Testing effectiveness (Phase 2)Ended earlyNCT01316692
What this trial is testing

Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma

Who this might be right for
Recurrent MelanomaStage IIIc MelanomaStage IV Melanoma
Vanderbilt-Ingram Cancer Center 12
Not applicableStudy completedNCT00974610
What this trial is testing

Study of Blood Samples From Patients With Malignant Melanoma, Metastatic Breast Cancer, Advanced Lung Cancer, Pancreatic Cancer, or Colorectal Cancer.

Who this might be right for
Breast CancerColorectal CancerLung Cancer+2 more
Cancer Trials Ireland 803
Large-scale testing (Phase 3)Looking for participantsNCT06488482
What this trial is testing

Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma

Who this might be right for
High-risk Melanoma
Uppsala University 1,792
Early research (Phase 1)Study completedNCT00020540
What this trial is testing

Biological Therapy in Treating Patients With Metastatic Melanoma or Metastatic Kidney Cancer

Who this might be right for
Kidney CancerMelanoma (Skin)
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Active Not RecruitingNCT04616248
What this trial is testing

In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8+10 more
University of Southern California 14
Next Page